Dementia and PDE5 inhibitors: A retrospective cohort study of veterans
This retrospective cohort study of over 878,000 U.S. male veterans with erectile dysfunction found that the use of PDE5 inhibitors was significantly associated with a reduced incidence and delayed onset of Alzheimer's, frontotemporal, and vascular dementia, suggesting a potential protective role for these medications that warrants further prospective investigation.